2023 IPO, Venture Capital and M&A Reports

2023 IPO, Venture Capital and M&A Reports

Publication

Related Documents

Related Solutions

Leveraging our sophisticated technical, market and legal experience to help clients effectively and efficiently manage complex transactions and get the deal done.
A premier corporate governance and disclosure practice providing timely, tailored and practical advice to public company clients based on in-depth experience and insight.
WilmerHale’s corporate lawyers have a long history of experience with cross-border deals involving mergers and acquisitions, public offerings and capital markets, venture capital, joint ventures and other transactions.
Leveraging regulatory and corporate experience to solve legal challenges for defense tech companies.
Helping clients launch their businesses and transform their innovative ideas into successful companies.
Globally connected lawyers counseling clients on complex business and policy matters.
Advising life sciences innovators, investors and industry leaders on complex transactions, legal issues and business challenges.
WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.
Critical industry insight and formidable strength across key practices.
We leverage technical knowledge, business acumen and legal experience to structure, prepare and negotiate innovative and effective technology-related agreements.

WilmerHale’s annual IPO, Venture Capital and M&A reports offer detailed insights into market conditions and provide comprehensive statistics and thoughtful analysis.

The 2023 IPO Report offers a detailed IPO market review and outlook, plus useful market metrics and need-to-know information for pre-IPO companies on the following topics:

  • Recent trends in the adoption of JOBS Act relief by emerging growth companies (EGCs).
  • What EGCs should consider as they prepare to exit EGC status. 
  • The resurgence of the reverse merger—an IPO alternative gaining traction in the life sciences sector.
  • New SEC rule amendments governing the use of Rule 10b5-1 trading plans.
  • What IPO companies should know about blackout provisions in light of new SEC insider trading policy disclosure requirements.
  • How a change to the Delaware General Corporation Law is expanding liability protection for company officers.
  • The new SEC rule that will require compensation clawbacks for exchange-listed public companies.
  • Evolving business needs, investor expectations and regulations that are shaping board composition.

The 2023 Venture Capital Report offers an in-depth US venture capital market analysis and outlook, including industry and regional breakdowns, and insights on the following topics:

  • The implications of new beneficial ownership reporting requirements for private companies under the Corporate Transparency Act.
  • Challenges posed by the expanding patchwork of state salary disclosure laws.
  • How SEC safe harbors can help pre-IPO companies weather the rigors of the “quiet period.”
  • What investors need to know about state taxes on qualified small business stock.
  • Deal term trends in VC-backed M&A transactions and convertible note, SAFE and venture capital financings.

The 2023 M&A Report offers a global M&A market review and outlook, as well as insights on the following topics: 

  • Trends in takeover defenses for public companies.
  • Recent cases that have placed Delaware corporations in a stronger position to limit shareholder books and records demands.
  • How deal terms compare in public and private company acquisitions.
  • Trends in VC-backed company M&A deal terms.

The relevant reports also showcase prominent recent capital markets, venture capital and M&A transactions.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link. (The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel